Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARON J. H., CONNELL A. M., LENNARD-JONES J. E., JONES F. A. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet. 1962 May 26;1(7239):1094–1096. doi: 10.1016/s0140-6736(62)92080-9. [DOI] [PubMed] [Google Scholar]
- BARON J. H., CONNELL A. M., LENNARD-JONES J. E. VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS. Br Med J. 1964 Jan 11;1(5375):89–92. doi: 10.1136/bmj.1.5375.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LENNARD-JONES J. E., LONGMORE A. J., NEWELL A. C., WILSON C. W., JONES F. A. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut. 1960 Sep;1:217–222. doi: 10.1136/gut.1.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOERTEL C. G., BARGEN J. A. A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis. Ann Intern Med. 1959 Nov;51:879–889. doi: 10.7326/0003-4819-51-5-879. [DOI] [PubMed] [Google Scholar]
- MORRISON L. M. Results of treatment of ulcerative colitis with salicylazosulfapyridine. Gastroenterology. 1952 May;21(1):133–138. [PubMed] [Google Scholar]
- SPRIGGS A. I., SMITH R. S., GRIFFITH H., TRUELOVE S. C. Heinz-body anaemia due to salicylazosulphapyridine. Lancet. 1958 May 17;1(7029):1039–1042. doi: 10.1016/s0140-6736(58)92005-1. [DOI] [PubMed] [Google Scholar]
- THIRKETTLE J. L., GOUGH K. R., READ A. E. Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy. Lancet. 1963 Jun 29;1(7296):1395–1397. doi: 10.1016/s0140-6736(63)92048-8. [DOI] [PubMed] [Google Scholar]
- TRUELOVE S. C., WATKINSON G., DRAPER G. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. Br Med J. 1962 Dec 29;2(5321):1708–1711. doi: 10.1136/bmj.2.5321.1708. [DOI] [PMC free article] [PubMed] [Google Scholar]